Inventor

SHAPIRO GIDEON

US77 patents

⚠️ This page may combine multiple inventors who share the name “SHAPIRO GIDEON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHAPIRO GIDEON

EPIZYME INC

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

CARM1 inhibitors and uses thereof

1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

CARM1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

CARM1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

PRMT1 inhibitors and uses thereof

Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof

CARM1 inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

Arginine methyltransferase inhibitors and uses thereof

CARM1 inhibitors and uses thereof

RUGEN HOLDINGS CAYMAN LTD

3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists

Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists

Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists

3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists

3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists

Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists

3,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists

ERAGEN BIOSCIENCES INC

Materials and methods for detection of nucleic acids

Materials and methods for detection of nucleic acids

Materials and methods for detection of nucleic acids

ENVIVO PHARMACEUTICALS INC

Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof

Phenoxymethyl heterocyclic compounds

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride

RIPKA AMY

1,2-disubstituted heterocyclic compounds

RUGEN HOLDINGS (CAYMAN) LTD

Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists

IRONWOOD PHARMACEUTICALS INC

Imidazotriazinone compounds

ROBINSON GARY

CAI-based systems and methods for the localized treatment of ocular and other diseases

OLIVER-SHAFFER PATRICIA

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

SHAPIRO GIDEON

Tetrasubstituted benzenes